Identification of fluorescence in situ hybridization assay markers for prediction of disease progression in prostate cancer patients on active surveillance

BACKGROUND: Prostate Cancer (PCa) is the second most prevalent cancer among U.S. males. In recent decades many men with low risk PCa have been over diagnosed and over treated. Given significant co-morbidities associated with definitive treatments, maximizing patient quality of life while recognizing...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Pestova, Katerina, Koch, Adam J., Quesenberry, Charles P., Shan, Jun, Zhang, Ying, Leimpeter, Amethyst D., Blondin, Beth, Sitailo, Svetlana, Buckingham, Lela, Du, Jing, Fei, Huixin, Van Den Eeden, Stephen K.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5749018/
https://ncbi.nlm.nih.gov/pubmed/29291731
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3910-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados